Advertisement

Migraine

Inability to Avoid Migraine Pain Causes Helplessness

Jul 05, 2022

Evidence indicates that pain avoidance behaviors are often heightened after recent pain events and can be disrupted when people experience uncontrollable stress. “This disruption can lead to malad...

Spectrum of Neurological Illnesses in Pregnancy - An Observational Study from a Tertiary Care Centre of Eastern India.

May 23, 2022

Neurological disorders in pregnancy may be observed in patients with a pre-existing neurological disorder; patients developing a primary neurological disorder during the course of pregnancy or puerper...

Interplay of Oral, Mandibular, and Facial Disorders and Migraine.

May 16, 2022

Migraine and other primary headache disorders can be localized in the face resembling facial or dental pain, indicating the influence of the trigeminovascular system in the structures innervated by th...

Beyond pain control: Outcome and treatment preferences in pediatric migraine.

May 09, 2022

The objective of this study was to describe treatment preferences and perceived quality of existing outcome measures among children and adolescents with migraine and their caregivers.Across discipline...

Only cervical vertebrae C0-C2, not C3 are relevant for subgrouping migraine patients according to manual palpation and pain provocation: secondary analysis of a cohort study.

Apr 25, 2022

Subgrouping of migraine patients according to the pain response to manual palpation of the upper cervical spine has been recently described. Based on the neuroanatomy and the convergence of spinal and...

Optic nerve ultrasonography in the evaluation of the relationship between arachnoid cyst and headache.

Apr 25, 2022

This study is aimed to show the difference between optic nerve sheath diameter (ONSD) values in migraine patients with and without arachnoid cysts from migraine patients and control groups, and to eva...

Impact of Greater Occipital Nerve Block on Photophobia Levels in Migraine Patients.

Apr 18, 2022

To study the effect of greater occipital nerve (GON) block on migraine-associated photophobia levels. Photophobia is one of the most bothersome symptoms reported by migraine patients. Studies investig...

The effect of nonsteroidal anti-inflammatory drugs on eye pain and migraine headache caused by trochleitis.

Apr 11, 2022

Trochleitis has been recognized as one of the causes of eye pain and migraine headaches. This study attempts to investigate the effect of ibuprofen on reducing eye pain and migraine headaches caused b...

Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study.

Apr 11, 2022

Galcanezumab, a monoclonal antibody to calcitonin gene-related peptide, was found to be safe and efficacious for the preventive treatment of chronic migraine based on the randomized, placebo-controlle...

P3 latency as a biomarker for the complexity of migraine with aura: Event-related potential study.

Mar 28, 2022

This study aimed to compare the P3 component between patients who have migraines with aura and healthy subjects, and to compare different subtypes of migraine with aura relative to the complexity of m...

Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients.

Mar 28, 2022

To assess cervical musculoskeletal impairments during the 4 phases of a migraine cycle in episodic migraine patients, controlling for the presence of concomitant neck pain.Differences in cervical musc...

Establishing content validity for the migraine Global Impression Item (mGI-I) assessment: a modified single-item migraine symptom severity questionnaire.

Mar 21, 2022

To establish content validity of a single-item, migraine-specific symptom severity questionnaire for completion by migraine patients, key family members (KFMs) of migraine patients, and Healthcare Pro...

Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine.

Mar 21, 2022

To assess the efficacy, safety, and predictors for poor responsiveness of botulinum toxin type A (BoNT-A) for chronic migraine in the adolescent and young adult population.A retrospective analysis of ...

[The efficacy and safety of Erenumab in patients with high-frequency episodic migraine according to the first Russian real-life study of the Research Center of Neurology].

Mar 14, 2022

To assess the effectiveness and safety of Erenumab, a monoclonal antibody to calcitonin gene-related peptide receptors, in patients with high-frequency episodic migraine (HFEM) in real-life study.35 p...

The relevance of migraine in the clinical spectrum of mitochondrial disorders.

Mar 14, 2022

Recent scientific evidence suggests a link between migraine and brain energy metabolism. In fact, migraine is frequently observed in mitochondrial disorders. We studied 46 patients affected by mitocho...

Treatment satisfaction with calcitonin gene-related peptide monoclonal antibodies as a new patient-reported outcome measure: A real-life experience in migraine.

Mar 07, 2022

To evaluate treatment satisfaction with galcanezumab as a patient-reported outcome measure (PROM) in migraine.Patients with ≥8 headache days/month that had failed at ≥3 medications were included....

Adjunctive treatment of chronic migraine using an oral dental device: overview and results of a randomized placebo-controlled crossover study.

Mar 07, 2022

To assess the nocioceptive input of habitual nocturnal jaw clenching that acts as a contributing factor in migraine pathogenesis.Habitual nocturnal jaw clenching has been implicated as a trigger, part...

Physical Activity is Associated with Less Analgesic Use in Women Reporting Headache-A Cross-Sectional Study of the German Migraine and Headache Society (DMKG).

Feb 28, 2022

The aim of this analysis is to determine whether regular physical activity is associated with less analgesic use in men and women suffering from headache disorders based on population-based cross-sect...

Sex Differences in Chronic Migraine: Focusing on Clinical Features, Pathophysiology, and Treatments.

Feb 28, 2022

This review provides an update on sex differences in chronic migraine (CM), with a focus on clinical characteristics, pathophysiology, and treatments.Approximately 6.8-7.8% of all migraineurs have CM,...

Assessing attack-related fear in headache disorders-Structure and psychometric properties of the Fear of Attacks in Migraine Inventory.

Feb 21, 2022

This study aimed to develop a self-report questionnaire for the assessment of attack-related fear in migraine, and to determine its factor structure as well as its psychometric properties by the prima...